Chand Basha Davuljigari

Dr. Chand Basha Davuljigari


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CDChand Basha Davuljigari
Chand Basha Davuljigari
FEFrederick Adams Ekuban
Frederick Adams Ekuban
CZCai Zong
Cai Zong
AFAlzahraa A. M. Fergany
Alzahraa A. M. Fergany
KMKota Morikawa
Kota Morikawa
GIGaku Ichihara
Gaku Ichihara
Acrylamide is a well characterized neurotoxicant known to cause neuropathy and encephalopathy in humans and experimental animals. To investigate the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in acrylamide-induced neuropathy, male C57Bl/6JJcl adult mice were exposed to acrylamide at 0, 200 or 300 ppm in drinking water and co-administered with subcutaneous injections of sulforaphane, a known activator of the Nrf2 signaling pathway at 0 or 25 mg/kg body weight daily for 4 weeks. Assessments for neurotoxicity, hepatotoxicity, oxidative stress as well as messenger RNA-expression analysis for Nrf2-antioxidant and pro-inflammatory cytokine genes were conducted. Relative to mice exposed only to acrylamide, co-administration of sulforaphane protected against acrylamide-induced neurotoxic effects such as increase in landing foot spread or decrease in density of noradrenergic axons as well as hepatic necrosis and hemorrhage. Moreover, co-administration of sulforaphane enhanced acrylamide-induced mRNA upregulation of Nrf2 and its downstream antioxidant proteins and suppressed acrylamide-induced mRNA upregulation of tumor necrosis factor alpha (TNF-α) and inducible nitric oxide synthase (iNOS) in the cerebral cortex. The results demonstrate that activation of the Nrf2 signaling pathway by co-treatment of sulforaphane provides protection against acrylamide-induced neurotoxicity through suppression of oxidative stress and inflammation. Nrf2 remains an important target for the strategic prevention of acrylamide-induced neurotoxicity.

20 September 2019 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
CDChand Basha Davuljigari
Chand Basha Davuljigari
RGRajarami Reddy Gottipolu
Rajarami Reddy Gottipolu

10 December 2018 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
SSS Saritha
S Saritha
CDChand Basha Davuljigari
Chand Basha Davuljigari
KKK Praveen Kumar
K Praveen Kumar
GRG Rajrami Reddy
G Rajrami Reddy
In this study, we evaluated the therapeutic efficacy of monoisoamyldimercaptosuccinic acid (MiADMSA) against individual and combined effects of arsenic (As) and lead (Pb) on the monoaminergic system and behavioral functions in rats. Pregnant rats were exposed to sodium metaarsenite (50 ppm) and lead acetate (0.2%) individually and in combination (As = 25 ppm + Pb = 0.1%) via drinking water from gestation day (GD) 6 to postnatal day (PND) 21. MiADMSA (50 mg/kg body weight) was given orally through gavage for 3 consecutive days to pups from PND 18 to PND 20. The results showed increases in synaptosomal epinephrine, dopamine, and norepinephrine levels with individual metal exposures and decreases with combined exposure to As and Pb in the cortex, cerebellum, and hippocampus in PND 21, PND 28, and 3 months age-group rats. We found decreased activity of mitochondrial monoamine oxidase in the selected brain regions following individual and combined exposures to Pb and As. In addition, rats treated with Pb and As alone or in combination showed significant deficits in open-field behavior, grip strength, locomotor activity, and exploratory behavior at PND 28 and 3 months of age. However, MiADMSA administration showed reversal effects against the As- and/or Pb-induced impairments in the monoaminergic system as well as in behavioral functions of rats. Our data demonstrated that the mixture of Pb and As induced synergistic toxicity to developing brain leading to impairments in neurobehavioral functions and also suggest therapeutic efficacy of MiADMSA against Pb- and/or As-induced developmental neurotoxicity.

26 September 2022 in Genes
Verified
Journal Article
Open access
PDF file
AEAbozer Elderdery
Abozer Elderdery
ETEntesar Mohammed Tebien
Entesar Mohammed Tebien
FAFawaz Obaidullah M Alenazy
Fawaz Obaidullah M Alenazy
AEAhmed M E Elkhalifa
Ahmed M E Elkhalifa
MSManar G. Shalabi
Manar G. Shalabi
JMjeremy mills
jeremy mills
Introduction: Metabolism methionine and of folate play a vital function in cellular methylation reactions, DNA synthesis and epigenetic process.However, polymorphisms of methionine have received much attention in recent medical genetics research. Objectives: To ascertain whether the common polymorphisms of the MTRR (Methionine Synthase Reductase) A66G gene could play a role in affecting susceptibility to Chronic Myeloid Leukemia (CML) in Sudanese individuals. Methods: In a case-controlled study, we extracted and analyzed DNA from 200 CML patients and 100 healthy control subjects by the PCR-RFLP method. Results: We found no significant difference in age orgender between the patient group and controls. The MTRR A66G genotypes were distributed based on the Hardy-Weinberg equilibrium (p > 0.05). The variation of MTRR A66G was less significantly frequent in cases with CML (68.35%) than in controls (87%) (OR = 0.146, 95% CI = 0.162–0.662, p < 0.002). Additionally, AG and GG genotypes and G allele were reducing the CML risk (Odds ratio [OR] = 0.365; 95% CI [0.179–0.746]; p = 0.006; OR = 0.292; 95% CI [0.145–0.590]; p = 0.001 and OR = 0.146; 95% CI [0.162–0.662]; p = 0.002 and OR = 2.0; 95% CI [1.3853–2.817]; respectively, (p = 0.000)). Conclusions: Our data demonstrated that heterozygous and homozygous mutant genotypes of MTRR polymorphisms were associated with decreased risk of developing CML in the Sudanese population.

1 March 2020 in Interdisciplinary Toxicology
Verified
Journal Article
Open access
PDF file
SNSreenivasulu Nagaraj
Sreenivasulu Nagaraj
CDChand Basha Davuljigari
Chand Basha Davuljigari
RGRajarami Reddy Gottipolu
Rajarami Reddy Gottipolu
Our earlier studies showed that exposure to lead (Pb) caused irreversible perturbations in the cholinergic system and neurobehavioral functions of female rats. In this study, we extended our studies to investigate the role of mitochondrial metabolic and oxidative enzymes in response to Pb exposure in pregnant and non-pregnant rats. Further, we evaluated the protective effect of α-tocopherol against Pb-induced mitochondrial dysfunction in female rats. Pregnant (GD 1 to PND 21) and non-pregnant rats were exposed to 0.2% Pb for the period of 42 days (6 weeks) while alpha (α)-tocopherol (100 mg/kg) was given orally through gavage for a period of 21 days (last 3 weeks) to Pb exposed pregnant and non-pregnant rats. Rats were decapitated on 7th day and 30th-day after the 42 days Pb exposure. Pb exposure decreased the activities of mitochondrial succinate dehydrogenase (SDH), isocitrate dehydrogenase (ICDH), superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) enzymes whereas the glucose-6-phosphate dehydrogenase (G6PDH), and malondialdehyde (MDA) levels increased in the cortex, cerebellum, and hippocampus at both 7th and 30th day points of pregnant and non-pregnant rats. Pb-induced alterations were greater in cortex coinciding with higher Pb levels observed in the cortex than hippocampus and cerebellum. Although the supplementation of α-tocopherol significantly reversed the Pb-induced alterations in the mitochondrial metabolic and oxidative enzymes, the reversal effect on Pb levels in different brain regions was marginal in both pregnant and non-pregnant rats. In conclusion, our data demonstrate that exposure to Pb significantly alters the mitochondrial enzymes in brain region-dependent manner and the effect of Pb was greater in non-pregnant female rats than pregnant rats. Further, the data provide evidence for the protective efficacy of α -tocopherol against Pb-toxicity.

1 January 2016 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
CDChand Basha Davuljigari
Chand Basha Davuljigari
GRGottipolu Rajarrami
Gottipolu Rajarrami
In this study, we examined the protective effect of calcium supplementation against the effects of prenatal high fat (HF) diet on offspring sensory-motor maturation and neurochemistry in rats. Pregnant rats were fed with HF and control diets from GD 6 to PND 21 and stopped at weaning. Calcium was supplemented as 0.02% in drinking water to the HF diet fed dams from GD 6 to PND 21. The results showed significant changes in righting reflex, slant board behavior and forelimb hang performance in offspring of HF diet fed rats. Significant increase was observed in serum total cholesterol and triglyceride levels at PND 28, PND 60 and 3 months age groups of HF diet fed rats. HF diet fed rats also showed significant decrease in acetylcholinesterase activity and accompanied by increase in acetylcholine levels in cortex, cerebellum and hippocampus at PND 28, PND 60 and 3 months age group rats. The mitochondrial superoxide dismutase and catalase activities decreased whereas MDA levels increased in all brain regions of selected age groups of HF diet fed rats. Significant deficits were also observed in spatial learning and memory behavior in HF diet fed rats. However, supplementation of calcium reversed the HF diet-induced alterations in neurobehavioral functions. In conclusion, these data indicate that consumption of HF diet during prenatal causes perturbations in neurobehavioral functions later in life further suggesting adequate calcium intake may be beneficial in treating the HF diet-induced toxicity.